Patent · US Active

Adenovirus 36 E4 orf 1 gene and protein and their uses

US8008436B2 · kind B2 · utility

3Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 30, 2006
Grant dateAug 30, 2011
Priority date
Expiry dateDec 9, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10332
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Expression of the E4 orf 1 gene of Ad-36 alone has been discovered to be responsible for the increased insulin sensitivity observed in Ad-36 infected animals, including increased adipogenesis. Ad-36 E4 orf 1 protein can be used to increase insulin sensitivity and ameliorate diabetes. Additionally, drugs that mimic the action of Ad-36 E4 orf 1 protein could be found. Ad-36 E4 orf 1 could also be used to increase fat cells in lipodystrophy. We have also discovered that Ad-36 infection in human skeletal muscle cells increased differentiation and insulin independent glucose uptake. It is expected that infection with Ad-36 E4 orf 1 gene will also cause these effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.